Skip to main content
Fig. 4 | Cardiovascular Diabetology

Fig. 4

From: Combined assessment of stress hyperglycemia ratio and glycemic variability to predict all-cause mortality in critically ill patients with atherosclerotic cardiovascular diseases across different glucose metabolic states: an observational cohort study with machine learning

Fig. 4

The ROC curves of SHR and GV as biomarkers for predicting 28-day mortality(A–C) and 90-day mortality(D–F). A SHR versus GV versus SHR+GV versus APACHE II, CCI, and GCS in NGR patients for predicting 28-day mortality. B SHR versus GV versus SHR+GV versus APACHE II, CCI, and GCS in Pre-DM patients for predicting 28-day mortality. C SHR versus GV versus SHR+GV versus APACHE II, CCI, and GCS in DM patients for predicting 28-day mortality. D SHR versus GV versus SHR+GV versus APACHE II, CCI, and GCS in NGR patients for predicting 90-day mortality. E SHR versus GV versus SHR+GV versus APACHE II, CCI, and GCS in Pre-DM patients for predicting 90-day mortality. F SHR versus GV versus SHR+GV versus APACHE II, CCI, and GCS in DM patients for predicting 90-day mortality.

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840